StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
JEGIL.XC$143.20+0.00%
Fair $143.20+0.0%

JEGIL.XC

JPMorgan European Growth & Income plc

Financial Services / Asset ManagementCboe UK

$143.20

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $143.20Fund rank 34/100 · Data gapFallback financials|
SA 30/D
F-Score: 2/9
Low Profitability

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 33.0/100

Data gap 34/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 68/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

30/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified. ROE is 3.0%, below the 5% threshold
Thesis & Journal · JEGIL.XCLocal privado en este navegador · JPMorgan European Growth & Income plc
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$605M

P/E

842.4x

↑

EV/EBITDA

N/A

•

ROE

3.0%

↓

Gross Margin

N/A

•

Debt/Equity

0.08

↓
52-Week Range$143
$97$97

TradingView lightweight chart

JEGIL.XC price, volumen y niveles de valoración

Último $96.80Periodo +16.5%
Fair value: $143.20

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-19.7%

FCF CAGR

+7.9%

FCF margin

64.1%

FCF / Net income

0.81x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $18.9M · net income $15.0M · FCF $12.1M

2022-FY → 2025-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

79.6%-14.0% pts

FCF margin

64.1%+37.6% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$18.9M$18.9M$76.4M$42.4M$36.4M
Net Income$15.0M$15.0M$74.0M$40.6M$34.1M
EPS0.040.040.170.090.08
Net Margin79.6%79.6%96.9%95.7%93.6%
Balance Sheet
Debt/Equity0.080.080.080.100.10
Current Ratio59.8459.84———
Cash Flow
Free Cash Flow$12.1M$12.1M$11.9M$11.3M$9.6M
Returns
ROE3.0%3.0%14.5%8.9%7.8%
Valuation
P/E842.35842.35598.021013.961063.06
P/B122.37122.3786.6090.4082.51
Growth & Yield
Revenue Growth-75.3%-75.3%80.0%16.6%—
EPS Growth-79.5%-79.5%84.1%19.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

612.0%

muy exigente

EPS terminal req.

$12.71

Spread vs growth

-691.5%

5Y implied EPS CAGR

237.3%

muy exigente

EPS terminal req.

$15.38

Spread vs growth

-316.8%

10Y implied EPS CAGR

92.6%

muy exigente

EPS terminal req.

$24.76

Spread vs growth

-172.1%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +0.0%

Total return

+0.0%

Start / end P/E

564.8x → 2750.0x

EPS bridge

0.17 → 0.04

Residual

-307.5%

EPS growth-79.5%
Multiple rerating+386.9%
Dividend+0.0%
Residual / FX / buybacks / cross-term-307.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.